Article information
Full text is only aviable in PDF
Bibliografía
[1.]
L.A. Dash, G.W. Comstock, J.P.G. Flynn.
Isoniazid preventive therapy. Retrospect and prospect.
Am Rev Respir Dis, 121 (1980), pp. 1.039-1.049
[2.]
International Union Against Tuberculosis Committee on Prophylaxis.
Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial Bull WHO, 60 (1982), pp. 555-564
[3.]
G.W. Comstock.
New data on preventive treatment with isoniazide. Editorial.
Ann Intern Med, 98 (1983), pp. 663-665
[4.]
L.B. Reichamn.
The age treshold for isoniazid chemoprophylaxis.
JAMA, 257 (1987), pp. 1.278
[5.]
L.S. Farer.
The current status of tuberculosis control efforts.
Am Rev Respir Dis, 134 (1986), pp. 402-407
[6.]
B. Miller, D.E. Snider.
Physician noncompliance with tuberculosis preventive measures. Editorial.
Am Rev Respir Dis, 135 (1987), pp. 1-2
[7.]
P.J. Geiseler, K.E. Nelson, R.G. Crispen.
Tuberculosis in physicians. Compliance with preventive measures.
Am Rev Respir Dis, 135 (1987), pp. 3-9
[8.]
D. Glasser.
Superiority of six months duration of isoniazid to twelve months in the programatic chemoprevention of tuberculosis in low-risk tuberculin reactors.
Am Rev Respir Dis, 129 (1984), pp. A199
[9.]
G.W. Comstock.
Prevention of tuberculosis among tuberculin. reactors: maximizing benefits, minimizing risks. Editorial.
JAMA, 256 (1986), pp. 2.729-2.730
[10.]
D.E. Snider, G.J. Caras, J.P. Koplan.
Preventive therapy with isoniazid. Cost-effectiveness of different duration of chemotherapy.
JAMA, 255 (1986), pp. 1.579-1.583
[11.]
American Thoracic Society/Centers for Disease Control.
Treatment of tuberculosis and tuberculosis infection in adults and children.
Am Rev Respir Dis, 134 (1986), pp. 355-363
[12.]
British Thoracic Society.
Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.
Thorax, 45 (1990), pp. 403-408
[13.]
M. Grossman, Ph.C. Hopewell, R.F. Jacobs, E.L. Kending, M.N. Smith.
Consensus: management of tuberculin-positive children without evidence of disease.
Pediat Inf Dis, 7 (1988), pp. 243-246
[14.]
V. Nazar, M. Oberle, C. Nolan.
Results of a directly-observed, intermittent isoniazid preventive therapy program in a shelter for homeless men.
Am Rev Respir Dis, 141 (1990), pp. A438
[15.]
L.S. Farer.
Chemoprophylaxis.
Am Rev Respir Dis, 125 (1982), pp. 102-107
[16.]
K.M. Citron.
Control and prevention of tuberculosis in Britain.
Br Med Bull, 44 (1988), pp. 704-716
[17.]
Centers for Disease Control.
A strategic plan for the elimination of tuberculosis in the United States.
MMWR, 38 (1989), pp. 1-25
[18.]
D.R. Leff, A.R. Leff.
Tuberculosis control policies in major Metropolitan Health Departments in the United States. IV. Standards in 1988.
Am Rev Respir Dis, 139 (1989), pp. 1.350-1.355
[19.]
J. Glassroth, W.C. Bailey, P.C. Hopewell, G. Schecter, J.W. Harden.
Why tuberculosis is not prevented.
Am Rev Respir Dis, 141 (1990), pp. 1.236-1.240
[20.]
A. Criado.
Quimioprofilaxis.
Arch Bronconeumol, 8 (1971), pp. 505-510
[21.]
P.de. March Ayuela.
El control y la profilaxis de la tuberculosis. Su aplicación actual en España. Perspectivas.
Arch Bronconeumol, 24 (1988), pp. 151-156
[22.]
M. Iseman, S.C. Edberg, J.J. Ellner, et al.
Improving methods for prevention of disease among the infected.
Am Rev Respir Dis, 134 (1986), pp. 413-414
[23.]
Hong Kong Chest Service/Tuberculosis Research Centre Madras/British Medical Research Council.
A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative. Results at 5 years.
Am Rev Respir Dis, 139 (1989), pp. 871-876
[24.]
A.K. Dutt, D. Moers, W.W. Stead.
Smearand culture-negative pulmonary tuberculosis, four-month short-course chemotherapy.
Am Rev Respir Dis, 139 (1989), pp. 867-870
[25.]
M.W. Mc Nicol, H. Thompson, J.F. Riordan, E. Forde, C.J. Alien.
Antituberculous Chemoprophylaxis with isoniazid-rifampicin.
Thorax, 39 (1984), pp. 223-224
[26.]
D.J. Girling.
Double blind controlled trial of Chemoprophylaxis againts tuberculosis in patients with silicosis in Hong Kong.
Am Rev Respir Dis, 141 (1990), pp. A438
[27.]
A. Monaco.
Antituberculosis Chemoprophylaxis in silicotics.
Bull Un Intern Tubero, 35 (1964), pp. 51-54
[28.]
Smith citado por Zorini O.A.en: La chimiopropylaxis antituberculeuse el ses rapports avec la B.C.G.
Congreso Europeo de Enfermedades del Tórax I.I, (1975),
[29.]
S.T. Kapetaneas, A. Rapti, I. Arapis, Ch.R. Chrisiotis, U. Anagnostopulo.
Short-term Chemoprophylaxis. Experience in Greece.
Am Rev Respir Dis, Iv (1990), pp. A437
[30.]
M.K. Felten, C.A. Merwe.
vander. Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment of tuberculosis.
Am Rev Respir Dis, 140 (1989), pp. 1.001-1.006
[31.]
D.E. Snider, L.S. Farer.
Preventive therapy for tuberculous infection: An intervention in need of improvement.
Editorial. Am Rev Respir Dis, 130 (1984), pp. 355-356
[32.]
L.J. Geiter, R.J. O’Brien, D.E. Kopanoff.
Short-course preventive therapy for tuberculosis.
Am Rev Respir Dis, 141 (1990), pp. A437
[33.]
G.W. Comstock, C. Baum, D.E. Snider.
Isoniazid prophylaxis among alaskan esquimos: A final report of the Betel isoniazid studies.
Am Rev Respir Dis, 119 (1979), pp. 827-830
[34.]
J. Grosset.
Regímenes actuales y nuevas drogas en quimioterapia y quimioprofilaxis de la tuberculosis.
Brol Un Intern Tuberc Enf Resp, 65 (1990), pp. 95-99
[35.]
J. Tsevat, W.C. Taylor, J.B. Wong, S.G. Pauker.
Decision analysis for isoniazid preventive therapy: take it or leave it?.
Am Rev Respir Dis, 137 (1988), pp. 1.247-1.248
[36.]
H.R. Held, S. Landi.
Binding of toxic metabolites of isoniazid by aconiazide.
J Pharm Sci, 69 (1980), pp. 1.284-1.287
[37.]
J.M. Mitchison, D.A. Mitchison.
In vitro observations on the suitability of new rifampycins for intermittent chemotherapy of tuberculosis.
Tubercle, 68 (1987), pp. 183-193
[38.]
Scottish Thoracic Society.
A controlled trial of chemotherapy in pulmonary tuberculosis of doubtful activity: Five year follow-up.
Tubercle, 44 (1963), pp. 39-46
[39.]
A. Lotte, F. Hatton, S. Perdrizet, A. Rouillon.
Chimioprophylaxie des tuberculoses primaires de 1’enfant et de 1’adolescent en France.
Bull WHO, 31 (1964), pp. 223-245
[40.]
British Thoracic, Tuberculosis, Association,.
Chemoprophylaxis against tuberculosis in Britain.
Tubercle, 54 (1973),
[41.]
K.H.K. Hsu.
La isoniazida en la prevención y tratamiento de la tuberculosis. Estudio de 20 años de duración referente a la eficacia en los niños.
JAMA, 1 (1975), pp. 21-24
[42.]
S. Grzybowski, J.D. Galbraith, E. Dorken.
Chemoprophylaxis trial in canadian eskimos.
Tubercle, 57 (1976), pp. 263-269
[43.]
S. Grzybowski, M.J. Ashley, G. Pinkus.
Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial.
Can Med Ass J, 114 (1976), pp. 607-611
[44.]
W.W. Stead, A.K. Dutt.
Changing faces of clinical tuberculosis.
En: Mycobacterium tuberculosis. Interaction with the immune system. 371-388,
[45.]
H.F. Lecouer, Ch. Truffot-Pernot, J.H. Grosset.
Experimental short-course preventive therapy of tuberculosis with rifampicin and pyrazinamide.
Am Rev Respir Dis, 140 (1988), pp. 1.189-1.193
[46.]
J.H. Grosset, H.F. Lecouer.
Truffot-Pernot Ch. Pyrazinamide in the Chemoprophylaxis of tuberculosis.
Am Rev Respir Dis, 142 (1990), pp. 1.467
[47.]
D.A. Mitchison.
Pyrazinamide in the Chemoprophylaxis of tuberculosis.
Am Rev Respir Dis, 142 (1990), pp. 1.467
[48.]
Anónimo.
Vigilancia del SIDA en España.
Situación a 21 de diciembre de 1990. Segunda parte. Bol Microbio! Sem, 49–50 (1990), pp. 1-3
[49.]
V. Navarro, J. Guix, G. Juan, et al.
Tuberculosis pulmonar con radiografía de tórax normal e infección por el virus de la inmunodeficiencia humana.
Enf Inf Microbiol Clin, 9 (1991), pp. 26-29
[50.]
American Thoracic Society.
Preventive therapy of tuberculous infection.
Am Rev Respir Dis, 110 (1974), pp. 371-378
[51.]
G.W. Comstock, PhQ. Edwards.
The competing risks of tuberculosis and hepatitis for adult tuberculin reactors.
Am Rev Respir Dis, 111 (1974), pp. 573-577
[52.]
D.N. Rose, C.B. Schechter, A.L. Silver.
The age threshold for isoniazid Chemoprophylaxis. A decisión analysis for low-risk tuberculin reactors.
JAMA, 256 (1986), pp. 2.709-2.713
[53.]
W.C. Taylor, M.D. Aronson, T.L. Delbanco.
Should young adults with a positive tuberculin test take isoniazid?.
Ann Intern Med, 94 (1981), pp. 808-813
[54.]
J. Tsevat, W.C. Taylor, J.B. Wong, S.G. Paulker.
Isoniazid for the tuberculin reactor: Take it or leave it.
Am Rev Respir Dis, 137 (1988),
[55.]
T.S. Moulding, A.G. Redeker, G.C. Kanel.
Twenty isoniazidassociated deaths in one State.
Am Rev Respir Dis, 140 (1989), pp. 700-705
[56.]
Centers for Disease Control.
The use of preventive therapy for tuberculous infection in the United States. Recomendations of the Advisory Committee for elimination of tuberculosis.
MMWR, 39 (1990), pp. 9-12
[57.]
W.W. Stead.
Tuberculin conversions: True of false?.
Am Rev Respir Dis, 119 (1979), pp. 171
[58.]
P. March-Ayuela.
de. Choosing an appropriate criterion for true or false conversion in serial tuberculin testin.
Am Rev Respir Dis, 141 (1990), pp. 815-820
[59.]
R.L. Sepúlveda, X. Ferrer, C. Latrach, R.V. Sorensen.
The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults.
Am Rev Respir Dis, 142 (1990), pp. 24-28
[60.]
American Thoracic Society.
Diagnostic standards and classification of tuberculosis.
Am Rev Respir Dis, 142 (1990), pp. 275-277
[61.]
K. Styblo.
Impact of Chemoprophylaxis and BCG vaccination on the overall tuberculosis situation.
Am Rev Respir Dis, 199 (1979), pp. 410
[62.]
British Thoracic Society.
Control and prevention of tuberculosis in Britain: and updated code of practice.
Br Med J, 300 (1990), pp. 995-999
Copyright © 1991. Sociedad Española de Neumología y Cirugía Torácica
